XML 14 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Unaudited Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Revenue        
Net product sales $ 3,470 $ 0 $ 5,872 $ 0
Total revenue 3,470 0 5,872 0
Operating expenses        
Cost of product sales 256 0 443 0
Research and development 30,439 19,093 89,735 57,666
Selling, general and administrative 21,139 7,390 66,319 18,915
Total operating expenses 51,834 26,483 156,497 76,581
Loss from operations (48,364) (26,483) (150,625) (76,581)
Interest (expense) income, net (2,381) 195 (3,426) 324
Net loss $ (50,745) $ (26,288) $ (154,051) $ (76,257)
Net loss per share, basic and diluted (usd per share) $ (1.93) $ (1.19) $ (6.15) $ (3.65)
Weighted-average common shares outstanding - basic and diluted (in shares) 26,226 22,125 25,055 20,900